SSCRIMED
Healthcare buyerUnderstand SCRIMED quicklyDemo, pilot, or pricing ownerConvert demo interest into a priced pilot pathInvestor, strategic partner, or faith-based clinic sponsorUnderstand SCRIMED's investable and sellable value safely
Pilot Programs

sellable-now · 60 days

60-Day Governed Automation Pilot

Run a selected workflow through deterministic synthetic evidence, AgentOS orchestration, TrustQA, observability, and executive review.

Duration60 days
EngagementRecommended synthetic-pilot range: $125k-$350k; $350k-$500k when multiple workflows, custom diligence, or executive proof packets expand scope
Included demos4
Decision metrics4
Commercial path4 demos

Target buyer

Enterprise healthcare teams validating workflow value, trust, and human-review design before integration

Recommended synthetic-pilot range: $125k-$350k; $350k-$500k when multiple workflows, custom diligence, or executive proof packets expand scope

Request this pilot
01Configured synthetic workflow packet
02AgentOS orchestration and approval map
03Atlas Trust Cards and proof packet
04Measured synthetic workflow outcome report
05Protected-pilot readiness decision register

Best demo entry paths

Use these demos to make the pilot conversation faster and easier for the buyer.

Synthetic Pilot Evaluation

CarePath Access Operations Demo

Access, care navigation, discharge, population health, and throughput leaders.

$125k-$350k for 45-90 days after sponsor and workflow owner are confirmed.
  • No autonomous outreach, diagnosis, treatment, emergency routing, PHI, or live workflow execution.
  • This is not emergency triage or patient outreach.
Open demo
Synthetic Pilot Evaluation

DocuTwin Documentation Review Demo

Clinical documentation, ambulatory operations, quality, and CMIO teams.

$125k-$350k standard; custom note-quality, source-trace, or specialty packet work priced separately.
  • No final note, EHR filing, diagnosis insertion, autonomous documentation, PHI, or clinical validation claim.
  • SCRIMED does not compete as a commodity monthly scribe seat.
Open demo
Synthetic Pilot Evaluation

PayerIQ Documentation Readiness Demo

Prior authorization, RCM, utilization-management, access, and finance transformation leaders.

$125k-$350k for a governed synthetic documentation-readiness pilot; buyer-specific policy mapping is separately scoped.
  • No live PHI, medical-necessity determination, payer submission, appeal filing, EHR writeback, or reimbursement guarantee.
  • The workbench identifies missing documentation and reviewer ownership; it does not determine medical necessity.
Open demo
Synthetic Pilot Evaluation

TrialCore Research Operations Demo

Research operations, oncology programs, academic medical centers, and trial networks.

$125k-$350k standard; research-network or multi-study scope requires custom pricing.
  • No patient outreach, enrollment decision, treatment recommendation, PHI, or production research-record mutation.
  • This is operational screening support, not enrollment approval.
Open demo

Included product proof

Inspectable demos ground the pilot in real product surfaces.

Decision metric 01

Time and friction baseline compared

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 02

Trust and trace completeness measured

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 03

Escalation and override design validated

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 04

Protected-pilot business case approved or declined

Measured against a buyer-approved operational baseline and governance boundary.

Activation requirements

The pilot starts only when buyer inputs and governance gates are explicit.

Buyer inputs

Required context

Business, workflow, and operating information needed to produce decision-grade evidence.

  • Named sponsor, workflow owner, and review team
  • Approved synthetic scenario and success metrics
  • Current-state process documentation without PHI
  • Security, governance, and interoperability constraints
Governance gates

Required controls

Conditions that keep the engagement auditable, human-reviewed, and healthcare-safe.

  • Synthetic data only
  • Human review before every external action
  • Audit and blocked-action evidence retained
  • No production connector access
Production exclusions

Not included

Capabilities that remain denied or require a separate protected-production approval path.

  • No diagnosis or treatment
  • No payer submission
  • No patient outreach
  • No production medical-record processing
ProposalDownload pilot proposal

Share the proposed scope, commercial model, metrics, inputs, gates, and exclusions.

StartRequest this pilot

Open the governed enterprise intake with the closest matching service offer selected.

ProofInspect all demos

Review the product evidence that can be packaged into the engagement.

CommercialReview pricing strategy

Inspect expansion paths from evaluation into protected pilot and enterprise license.

AcceleratorReview market alignment

Inspect benchmark context, price bands, and demo-to-pilot routing.